Alzheimer disease (AD), a complex neurodegenerative disorder, has become a major public health concern given its rapidly increasing prevalence and the long duration coupled with high cost of care. Successful disease-modifying therapy is still lacking, despite a decade of remarkable
advances in our understanding of both the pathology and the risks associated with AD. In recent years, it has become obvious that neuritic plaques and neurofibrillary tangles, the neuropathological hallmarks of AD, are not exclusive to demented individuals. In fact, as many as 30% of
individuals older than 75 years of age who are considered clinically normal at the time of death will receive a post-mortem diagnosis of possible or probable AD based on neuropathological findings - a condition we define as Asymptomatic AD (ASYMAD). This realization certainly poses a challenge
to the neuropathological diagnosis, which is still considered the gold standard. In addition, the recognition of ASYMAD has begun to shift the focus of research from risk and pathology to the identification of protective factors, and thereby the prevention of disability and disease which have
been relatively understudied. Much of our recent efforts have focused on what might be allowing these older individuals to remain resilient to pathology compared to many who have succumbed to it. Most of our investigations to date have centered on the Baltimore Longitudinal Study of Aging.
Here, we provide a historical background and highlight the combined clinical, pathologic and morphometric findings related to ASYMAD. We believe that a better understanding of changes occurring during this apparently asymptomatic state may be seminal to our understanding of the mechanisms
that underlie the maintenance of cognitive health or halt the progression of the disease. Based on their findings from two large communitybased, cohort studies, the Religious Orders Study and the Rush Memory and Aging Project, Negash and colleagues propose a provocative paradigm shift
in consideration of the neurobiology of healthy aging and dementia. They highlight the need for research identifying factors that promote resistance to age-related pathology. Within the framework of cognitive reserve, many factors thought to modify or mediate the association between neuropathology
and cognition are also discussed. Vascular dementia is also challenging field, and O'Brien reviews the relationship among Alzheimer's brain pathology, cerebral infarcts and cerebral atherosclerosis, all of which are common in autopsy brains of patients enrolled in longitudinal
prospective cohorts. The relative contribution of each of these factors to overall cognitive function or dementia is unclear. O'Brien offers that each seems to be an independent predictor of dementia and that individual's ability to withstand the toxic effects of amyloid deposition
might be due to the lack of additional coexisting pathologies....
Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.